Virupaksha Organics Ltd.: A Leading Producer of Fexofenadine HCl

Virupaksha Organics Ltd. has solidified its position as a key player in the global pharmaceutical industry, particularly in the production of Fexofenadine Hydrochloride (HCl), a widely used antihistamine for treating allergy symptoms. With cutting-edge manufacturing facilities in Telangana, India, Virupaksha adheres to the highest international standards of quality and compliance, ensuring the production of top-quality Fexofenadine HCl for both domestic and international markets.
Virupaksha’s facilities are certified by WHO-GMP, ISO 9001, and ISO 14001, which attests to the company’s commitment to maintaining rigorous quality control and environmental management. The company’s production capabilities and advanced R&D enable it to deliver cost-effective, high-purity APIs that meet the growing global demand for Fexofenadine HCl.
With its focus on innovation, sustainability, and customer satisfaction, Virupaksha Organics continues to be a trusted partner for pharmaceutical companies worldwide. Its strategic approach to producing APIs like Fexofenadine HCl positions the company as a leader in the antihistamine market, contributing to improved healthcare outcomes for millions of patients globally.
As the demand for allergy medications rises, Virupaksha Organics remains at the forefront of API production, demonstrating excellence in pharmaceutical manufacturing and reinforcing its status as a premier producer of Fexofenadine HCl.

Other Latest News
- ASP Isotopes plans JSE listing to enhance local investment opportunities April 25, 2025 1:38 pm IOL ASP Isotopes, which uses its own South Africa developed technology to enrich isotopes, plans to add to its 2022 Nasdaq listing with a listing on the Main Board of the Johannesburg Stock Exchange. The company, owned by its CEO Paul Mann and US-based …
- Assisted Reproductive Technology Market worth US$6.02 Billion by 2030 with 7.0% CAGR | MarketsandMarkets™. April 25, 2025 12:30 pm EIN Presswire Delray Beach, FL, April 25, 2025 (GLOBE NEWSWIRE) — The global Assisted Reproductive Technology Market, valued at US$4.02 billion in 2024, is forecasted to grow at a robust CAGR of 7.0%, reaching US$4.29 billion in 2025 and an impressive US$6.02 billion …
- Bristol-Myers Squibb Company (NYSE:BMY) Q1 2025 Earnings Call Transcript April 25, 2025 12:22 pm Insider Monkey Bristol-Myers Squibb Company (NYSE:BMY) Q1 2025 Earnings Call Transcript April 24, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is $1.8, expectations were $1.49. Operator: Good day, and welcome to the Bristol-Myers Squibb …
- Dow Inc. (NYSE:DOW) Q1 2025 Earnings Call Transcript April 25, 2025 12:22 pm Insider Monkey Dow Inc. (NYSE:DOW) Q1 2025 Earnings Call Transcript April 24, 2025 Dow Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.02. Operator: A brief question and answer session will follow the formal presentation. If you would like …
- Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders April 25, 2025 12:08 pm EIN Presswire WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four …
- Weekly Japanese Industry and Policy News: 19 Apr – 25 Apr,2025 April 25, 2025 12:06 pm EU-Japan Centre for Industrial Cooperation The EU Japan Centre is releasing a weekly press review covering Japan's economic and policy matters. Economic News ▶ Security Issues Separate from Japan-U.S. Tariff Talks; Japan Govt Wary Trump Will Try to Link the Two 19 Apr, 2025 During recent U. …
- China Reportedly Begins Exempting Key US Imports From Tariffs, Including Pharma And Aerospace Parts April 25, 2025 12:00 pm Benzinga In a move indicating a possible easing of trade tensions, China has reportedly started to exempt some U.S. imports from high tariffs and is proactively seeking feedback from companies on other key items they want excluded from them. What Happened: …
- This pharma stock hits upper circuit even as market crash – Here's why April 25, 2025 11:43 am India TV News Mumbai: Shares of Sudharshan Pharma Industries hit a five per cent upper circuit on Friday, i.e. on April 25, 2025, even as the stock market gave up early gains to trade lower. The BSE benchmark traded 174.24 points lower at 79,627.19, and the Nifty quoted …
- Entod Pharma receives CDSCO marketing approval for an eye drop to slow down myopia progression in children April 25, 2025 11:03 am Pharmabiz.com Entod Pharmaceuticals, a global research-driven ophthalmic company, announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for a new eye formulation developed to slow the progression of myopia in …
- US business lobby in China: Some pharma firms reporting tariff exemptions April 25, 2025 10:12 am Yahoo Finance By Andrew Silver and Brenda Goh SHANGHAI (Reuters) -Pharmaceutical companies in China are reporting that they have been able to import some drugs over the past week with tariff exemptions, the Beijing-based American Chamber of Commerce said on Friday. The …
- IT sector faces limited upside amid global uncertainty and tariff risks: Sandip Sabharwal April 25, 2025 9:37 am The Economic Times "I would think that the downsides could be limited for many of these companies given the fact that they are zero debt, most of them, and cash flow generating companies with a decent dividend yield, but the upside also is limited given the lack of …
- Healthcare and Consumer Care Ayurveda Products Anticipated to Reach USD 83.6 Billion, at a Notable 16.85% CAGR by 2035 April 25, 2025 9:33 am EIN Presswire Healthcare and Consumer Care Ayurveda Products Market: Blending Tradition with Modern Wellness Trends US, NY, UNITED STATES, April 25, 2025 /EINPresswire.com/ — Market Overview The Healthcare and Consumer Care Ayurveda Products Market is …
- How will Trump’s tariffs impact my Stocks and Shares ISA? April 25, 2025 8:51 am The Motley Fool UK Image source: Getty Images It’s almost impossible not to have some exposure to tariffs and geopolitical risks inside a diversified Stocks and Shares ISA. I’ve been looking through my own portfolio to assess — as best as I can — which stocks are more at …
- NETRIS Pharma Announces Positive Interim Phase II Results for NP137 in combination with anti-PD(L)1 April 25, 2025 6:00 am EIN Presswire Confirmation of NP137 Potential to Overcome Resistance to Immune Checkpoint – Clinical Trial Design and Interim Results to be Presented at ASCO and ESMO 2025 LYON, FRANCE, April 25, 2025 /EINPresswire.com/ — NETRIS Pharma, a clinical-stage …
- MSMEs poised to capture global generics & biosimilars markets through collaborative efforts: FPME April 25, 2025 4:21 am Pharmabiz.com Amid evolving global trade dynamics and geopolitical shifts, the Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) underscores the increasing significance of Indian pharmaceutical companies and MSMEs in shaping the future of global …
- IMF lashes out at China and US over trade war as tariff turmoil takes toll on global corporate titans April 24, 2025 10:25 pm This Is Money By ALEX BRUMMER CITY EDITOR IN WASHINGTON Updated: 17:03 EDT, 24 April 2025 The US and China were last night urged to end their damaging trade war or risk plunging the world into recession. As companies across the globe laid bare the impact of tariffs on …
- Pharma tariffs, and a ‘sunshine day’ for biotech stocks April 24, 2025 10:01 pm STAT – Massachusetts Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. …
- Trump’s tariffs threaten Ireland’s pharma fortune April 24, 2025 9:05 pm The Financial Times Unlock the White House Watch newsletter for free Your guide to what Trump’s second term means for Washington, business and the world There was once an English-speaking country that tried to make itself economically self-sufficient by imposing tariffs and …
- Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025 April 24, 2025 8:01 pm EIN Presswire COPENHAGEN, Denmark, April 24, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2025 financial results and provide a business update on Thursday, May 1, 2025, after the close of the U.S. financial …
- Belgium issues rare category management decision against pharma companies April 24, 2025 6:51 pm Global Competition Review Credit: Shutterstock.com/Tyler Olson Johnson & Johnson, Boehringer Ingelheim and Haleon have been ordered to pay a combined €11.2 million fine for what Belgium’s Competition Authority has called a “textbook” example of anticompetitive category …
- Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight April 24, 2025 5:00 pm EIN Presswire New York, USA, April 24, 2025 (GLOBE NEWSWIRE) — Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight The neuroprosthetics market is experiencing significant …
- Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight April 24, 2025 5:00 pm EIN Presswire New York, USA, April 24, 2025 (GLOBE NEWSWIRE) — Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sarcopenia market remains largely untapped, with significant …
- Roche moves to mitigate US tariff impact amid discussions with global governments April 24, 2025 2:59 pm Fierce Pharma Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning the President Trump administration for an exemption. Roche is trying to reason with the U.S. government that, as long as the Swiss …
- The Escalator: Galapagos, Zealand Pharma, IPG Mediabrands Health and more April 24, 2025 2:29 pm Medical Marketing and Media New hires: The Food and Drug Administration hired Lowell Zeta as deputy commissioner for strategic initiatives, Timothy Schell as acting director for the Center for Veterinary Medicine and Craig Taylor as the acting chief information officer. Zymeworks …
- PDG-FDA Town Hall Notes — DSCSA Readiness Is At Hand April 24, 2025 2:00 pm Bioprocess Online By Carl Accettura, Global Pharma Advisory The PDG-FDA Virtual DSCSA Town Hall on March 26 focused on manufacturer’s readiness, and key players highlighted significant strides toward Drug Supply Chain Security Act (DSCSA) compliance with a focus on data …